Sign in

CIK 0001661059 · Non-accelerated filer<br>Smaller reporting company

NextCure, Inc.

Sign in to watch
Ticker
NXTC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475231247
Phone
240-399-4900
Business address
2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
  1. PRE 14A Proxy Proxy Statement (Preliminary)
  2. 8-K Event Regulation FD disclosure
  3. 10-K Report Annual Report
  4. 8-K Event Results of operations
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 8-K Event Delisting notice
  14. 8-K Event Other events
  15. 8-K Event Other events
  16. 8-K Event Regulation FD disclosure
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 8-K Event Regulation FD disclosure
  20. 10-Q Report Quarterly Report

Page 6 of 20 · 400 filings